Henan Sainuo Biological Pharmaceutical

Henan Sainuo Biological Pharmaceutical is a Chinese pharmaceutical company specialized in the research, development, and high-volume production of heparin-based anticoagulant medications. Founded in 2007 and headquartered in Henan Province, the company has established a vertically integrated supply chain for biochemical drugs, ranging from crude extraction to the manufacturing of high-purity Active Pharmaceutical Ingredients (APIs) and finished sterile injections. Its core product portfolio includes well-established anticoagulants such as Heparin Sodium, Enoxaparin Sodium, and Nadroparin Calcium, which are critical for treating cardiovascular diseases and managing surgery-related thrombosis. The company is recognized as a national high-tech enterprise in China and serves a diverse global market through its GMP-certified facilities. Sainuo is publicly traded on China's National Equities Exchange and Quotations (NEEQ) under the stock symbol 836859.